169 related articles for article (PubMed ID: 9619782)
1. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
2. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
3. Effect of cilastatin on renal handling of vancomycin in rats.
Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
[TBL] [Abstract][Full Text] [Related]
4. [Nephrotoxicity and drug interaction of vancomycin (2)].
Toyoguchi T; Nakagawa Y
Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
[TBL] [Abstract][Full Text] [Related]
5. Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
Hakeam HA; AlAnazi L; Mansour R; AlFudail S; AlMarzouq F
Infect Dis (Lond); 2019 Aug; 51(8):578-584. PubMed ID: 31122098
[No Abstract] [Full Text] [Related]
6. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
Pais GM; Marianski S; Valdez K; Melicor RP; Liu J; Rohani R; Chang J; Tong SYC; Davis JS; Scheetz MH
Br J Pharmacol; 2024 Mar; 181(5):670-680. PubMed ID: 37696768
[TBL] [Abstract][Full Text] [Related]
7. The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats.
Yoshiyama Y; Yazaki T; Wong PC; Beauchamp D; Kanke M
J Infect Chemother; 2001 Dec; 7(4):243-6. PubMed ID: 11810591
[TBL] [Abstract][Full Text] [Related]
8. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
Kouda M
Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotoxicity and drug interaction of vancomycin].
Toyoguchi T; Nakagawa Y; Watanabe H
Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
[TBL] [Abstract][Full Text] [Related]
11. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
Im DS; Shin HJ; Yang KJ; Jung SY; Song HY; Hwang HS; Gil HW
Toxicol Lett; 2017 Aug; 277():9-17. PubMed ID: 28549670
[TBL] [Abstract][Full Text] [Related]
12. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
[TBL] [Abstract][Full Text] [Related]
13. Cilastatin protects against imipenem-induced nephrotoxicity
Huo X; Meng Q; Wang C; Zhu Y; Liu Z; Ma X; Ma X; Peng J; Sun H; Liu K
Acta Pharm Sin B; 2019 Sep; 9(5):986-996. PubMed ID: 31649848
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
Totsuka K; Shiseki M; Kikuchi K; Matsui Y
J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
Humanes B; Jado JC; Camaño S; López-Parra V; Torres AM; Álvarez-Sala LA; Cercenado E; Tejedor A; Lázaro A
Biomed Res Int; 2015; 2015():704382. PubMed ID: 26504822
[TBL] [Abstract][Full Text] [Related]
16. Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity.
Marre R; Schulz E; Hedtke D; Sack K
Infection; 1985; 13(4):190-2. PubMed ID: 4044046
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
18. Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
Toyoguchi T; Ebihara M; Ojima F; Hosoya J; Shoji T; Nakagawa Y
J Pharm Pharmacol; 2000 Mar; 52(3):327-31. PubMed ID: 10757422
[TBL] [Abstract][Full Text] [Related]
19. Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.
Hori Y; Aoki N; Kuwahara S; Hosojima M; Kaseda R; Goto S; Iida T; De S; Kabasawa H; Kaneko R; Aoki H; Tanabe Y; Kagamu H; Narita I; Kikuchi T; Saito A
J Am Soc Nephrol; 2017 Jun; 28(6):1783-1791. PubMed ID: 28052987
[TBL] [Abstract][Full Text] [Related]
20. Renal clearance of imipenem in children.
Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
